Home › Funds › Jones Hill Capital LP › LXEO
Jones Hill Capital LP position in LXEO
LEXEO THERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 593,737 shares of LXEO (LEXEO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.34% of its reported portfolio and ranking #30 among its reported holdings. Jones Hill Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's LXEO position evolved
Jones Hill Capital LP first disclosed a stake in LXEO in Q3 2026 at 593,737 shares (US$2.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 593.74K | $2.01M | New |
About LXEO and 13F data
LXEO (LEXEO THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in LXEO — the largest reported positions include MONTANOVA CAPITAL, LLC (US$29.7M), Affinity Asset Advisors, LLC (US$27.0M), Frazier Life Sciences Management, L.P. (US$22.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LXEO
- MONTANOVA CAPITAL, LLC 6.38M sh · $29.72M · Q2 2026
- Affinity Asset Advisors, LLC 5.81M sh · $27.03M · Q2 2026
- Frazier Life Sciences Management, L.P. 4.82M sh · $22.46M · Q2 2026
- Vestal Point Capital, LP 4.32M sh · $20.11M · Q2 2026
- Paradigm Biocapital Advisors LP 4.18M sh · $19.44M · Q2 2026
- 683 Capital Management, LLC 1.88M sh · $8.73M · Q2 2026
- Avoro Capital Advisors LLC 1.49M sh · $6.93M · Q2 2026
- Spruce Street Capital LP 928.59K sh · $4.32M · Q2 2026
- DAFNA Capital Management LLC 377.06K sh · $1.76M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held LXEO?
Jones Hill Capital LP has disclosed LXEO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Jones Hill Capital LP's current position in LXEO?
As of Q3 2026, Jones Hill Capital LP holds 593.74K shares of LXEO (LEXEO THERAPEUTICS INC), valued at $2.01M, representing 0.34% of its reported portfolio and ranking #30.
Has Jones Hill Capital LP been buying or selling LXEO?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in LXEO.
Which other funds hold LXEO?
Other major institutional holders of LXEO include MONTANOVA CAPITAL, LLC, Affinity Asset Advisors, LLC, Frazier Life Sciences Management, L.P., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.